Published in J Am Soc Nephrol on March 29, 2012
A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants. Eur J Endocrinol (2013) 0.99
The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis. BMC Neurol (2015) 0.84
Extracellular potassium homeostasis: insights from hypokalemic periodic paralysis. Semin Nephrol (2013) 0.82
Inward-rectifying potassium channelopathies: new insights into disorders of sodium and potassium homeostasis. Pediatr Nephrol (2014) 0.77
Thyrotoxic hypokalemic periodic paralysis in an African male: a case report. Clin Case Rep (2014) 0.75
Hypokalemic Paralysis Complicated by Concurrent Hyperthyroidism and Hyperaldosternoism: A Case Report. Am J Case Rep (2017) 0.75
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology (2008) 2.87
Thyrotoxic periodic paralysis. Mayo Clin Proc (2005) 2.73
Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell (2010) 2.42
In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ (1991) 1.66
Early diagnosis of thyrotoxic periodic paralysis: spot urine calcium to phosphate ratio. Crit Care Med (2006) 1.51
Laboratory tests to determine the cause of hypokalemia and paralysis. Arch Intern Med (2004) 1.49
Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current. Neurology (1999) 1.36
Androgens stimulate preoptic area Na+,K+-ATPase activity in male rats. Neurosci Lett (1987) 1.17
Effects of pH on potassium: new explanations for old observations. J Am Soc Nephrol (2011) 1.12
Novel etiopathophysiological aspects of thyrotoxic periodic paralysis. Nat Rev Endocrinol (2011) 1.07
Hormonal and pharmacological modification of plasma potassium homeostasis. Fundam Clin Pharmacol (2010) 1.06
Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis. J Biol Chem (2011) 1.00
Hyperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis. Lancet (1991) 0.99
The effects of thyroid hormones on 3H-ouabain binding site concentration, Na,K-contents and 86Rb-efflux in rat skeletal muscle. Pflugers Arch (1986) 0.94
Therapeutic analysis in Chinese patients with thyrotoxic periodic paralysis over 6 years. Eur J Endocrinol (2009) 0.88
INa and IKir are reduced in Type 1 hypokalemic and thyrotoxic periodic paralysis. Muscle Nerve (2010) 0.87
Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci U S A (2008) 2.62
Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci U S A (2006) 1.93
DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol (2012) 1.93
WNK1 activates SGK1 to regulate the epithelial sodium channel. Proc Natl Acad Sci U S A (2005) 1.76
Regulation of renal outer medullary potassium channel and renal K(+) excretion by Klotho. Mol Pharmacol (2009) 1.75
Intersectin links WNK kinases to endocytosis of ROMK1. J Clin Invest (2007) 1.67
Uromodulin upregulates TRPV5 by impairing caveolin-mediated endocytosis. Kidney Int (2013) 1.44
Evidence for endocytosis of ROMK potassium channel via clathrin-coated vesicles. Am J Physiol Renal Physiol (2002) 1.39
WNK1 activates SGK1 by a phosphatidylinositol 3-kinase-dependent and non-catalytic mechanism. J Biol Chem (2005) 1.37
PIP2 activates TRPV5 and releases its inhibition by intracellular Mg2+. J Gen Physiol (2005) 1.35
Conformational changes of pore helix coupled to gating of TRPV5 by protons. EMBO J (2005) 1.31
Mechanism and molecular determinant for regulation of rabbit transient receptor potential type 5 (TRPV5) channel by extracellular pH. J Biol Chem (2003) 1.27
Protein kinase C inhibits caveolae-mediated endocytosis of TRPV5. Am J Physiol Renal Physiol (2008) 1.27
Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart. Nat Commun (2012) 1.25
IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway. J Clin Invest (2011) 1.18
Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase. J Biol Chem (2009) 1.17
Dietary potassium restriction stimulates endocytosis of ROMK channel in rat cortical collecting duct. Am J Physiol Renal Physiol (2003) 1.14
Protein kinase C inhibits ROMK1 channel activity via a phosphatidylinositol 4,5-bisphosphate-dependent mechanism. J Biol Chem (2003) 1.14
Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice. Am J Pathol (2009) 1.12
Role of with-no-lysine [K] kinases in the pathogenesis of Gordon's syndrome. Pediatr Nephrol (2006) 1.11
Association of urinary sodium/potassium ratio with blood pressure: sex and racial differences. Clin J Am Soc Nephrol (2011) 1.06
Activation of PI3-kinase stimulates endocytosis of ROMK via Akt1/SGK1-dependent phosphorylation of WNK1. J Am Soc Nephrol (2011) 1.05
Structural determinants and specificities for ROMK1-phosphoinositide interaction. Am J Physiol Renal Physiol (2002) 1.02
Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis. J Biol Chem (2011) 1.00
Calcium-sensing receptor decreases cell surface expression of the inwardly rectifying K+ channel Kir4.1. J Biol Chem (2010) 0.99
Serum and glucocorticoid-induced kinase (SGK) 1 and the epithelial sodium channel are regulated by multiple with no lysine (WNK) family members. J Biol Chem (2010) 0.99
Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models. Hum Mol Genet (2010) 0.98
The N-terminal extracellular domain is required for polycystin-1-dependent channel activity. J Biol Chem (2004) 0.93
Distal potassium handling based on flow modulation of maxi-K channel activity. Curr Opin Nephrol Hypertens (2009) 0.93
Domains of WNK1 kinase in the regulation of ROMK1. Am J Physiol Renal Physiol (2008) 0.92
WNK1 promotes PIP₂ synthesis to coordinate growth factor and GPCR-Gq signaling. Curr Biol (2011) 0.88
Recent advances in distal tubular potassium handling. Am J Physiol Renal Physiol (2011) 0.87
Kidney-specific WNK1 inhibits sodium reabsorption in the cortical thick ascending limb. Am J Physiol Renal Physiol (2012) 0.86
WNK4 kinase stimulates caveola-mediated endocytosis of TRPV5 amplifying the dynamic range of regulation of the channel by protein kinase C. J Biol Chem (2010) 0.86
WNK1 protein kinase regulates embryonic cardiovascular development through the OSR1 signaling cascade. J Biol Chem (2013) 0.85
The Drosophila NKCC Ncc69 is required for normal renal tubule function. Am J Physiol Cell Physiol (2012) 0.85
An emerging role for SPAK in NCC, NKCC, and blood pressure regulation. J Am Soc Nephrol (2010) 0.84
The mechanism of hypocalciuria with NaCl cotransporter inhibition. Nat Rev Nephrol (2011) 0.83
Mechanism of urinary calcium regulation by urinary magnesium and pH. J Am Soc Nephrol (2008) 0.82
Extracellular potassium homeostasis: insights from hypokalemic periodic paralysis. Semin Nephrol (2013) 0.82
Kidney-specific WNK1 regulates sodium reabsorption and potassium secretion in mouse cortical collecting duct. Am J Physiol Renal Physiol (2012) 0.81
Regulation of TRPV5 single-channel activity by intracellular pH. J Membr Biol (2007) 0.80
Flow-induced activation of TRPV5 and TRPV6 channels stimulates Ca(2+)-activated K(+) channel causing membrane hyperpolarization. Biochim Biophys Acta (2013) 0.80
On the role of pore helix in regulation of TRPV5 by extracellular protons. J Membr Biol (2007) 0.80
Inhibition of ROMK potassium channel by syntaxin 1A. Am J Physiol Renal Physiol (2004) 0.79
Inward-rectifying potassium channelopathies: new insights into disorders of sodium and potassium homeostasis. Pediatr Nephrol (2014) 0.77
Corrigendum: WNK1 kinase balances T cell adhesion versus migration in vivo. Nat Immunol (2017) 0.75
Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance. J Clin Endocrinol Metab (2015) 0.75
Acquired hypocalciuric hypercalcemia in a patient with CKD. Am J Kidney Dis (2013) 0.75